What did @invitewellnessllc actually say?
The creator's argument, in plain terms, is this: estrogen rising on TRT is expected and not inherently dangerous, but blocking it with an aromatase inhibitor like anastrozole can cause real symptoms. They told viewers that if a guy is experiencing "inconsistent libido," "mental fog," "anxiety," "low mood," and "joint pain" on TRT, the AI might be the problem, not the estrogen. They also pushed back on the framing that estrogen being "out of the reference range" is automatically a problem, arguing the conversion of testosterone to estrogen is physiologically normal. The critique of reflexive AI prescribing is the core of their point, and it's worth taking seriously, even if a few edges of the argument needed more precision.
Does the science back this up?
Mostly, yes, and more than many TRT influencers manage. The claim that testosterone aromatizes into estradiol is basic endocrinology. The concern about over-suppressing estrogen with anastrozole is well-supported in the literature. A 2013 study by Finkelstein et al. in the New England Journal of Medicine showed that estrogen, not just testosterone, is responsible for maintaining libido, fat distribution, and bone density in men. When estrogen was suppressed pharmacologically, sexual function and mood deteriorated even when testosterone remained adequate. That's not a fringe finding.
The symptom list the creator gives, including joint pain, low mood, and brain fog, maps directly onto documented side effects of over-suppression with anastrozole. A 2017 review by Ramasamy et al. in the Journal of Urology noted that AI use in TRT patients is often unnecessary and can cause bone mineral density loss, mood dysregulation, and lipid changes. The science genuinely does support skepticism toward routine AI co-prescribing.
What did they get wrong (or right)?
The creator got the broad argument right but muddied the nuance. The claim that estrogen being "out of the reference range is not an issue" is too blunt. Severely elevated estradiol, typically above 60 pg/mL in men on TRT, can cause gynecomastia, fluid retention, and cardiovascular strain in some individuals. The Finkelstein data shows estrogen matters in both directions. There are real clinical situations where a short course of anastrozole is appropriate, particularly if a patient has symptomatic gynecomastia or very high aromatization.
They're right that anastrozole is widely overused in TRT protocols, and right that its side effect profile is underappreciated by patients. But "estrogen being out of the reference range is not an issue" overstates the case. It should have been framed as: mildly elevated estradiol in the absence of symptoms rarely requires intervention. That's a meaningfully different claim, and a more defensible one.
What should you actually know?
The practical bottom line here is that anastrozole is a legitimate pharmaceutical tool that carries real risks when used without clinical justification. A 2019 analysis by Barbonetti et al. in Andrology found that a significant proportion of men on TRT who are prescribed AIs have no documented clinical indication for them beyond lab values alone. That's a problem.
Estradiol in men on TRT should be interpreted in context, alongside symptoms, hematocrit, and total testosterone levels, not treated as an automatic medication trigger the moment it exceeds a reference range printed on a lab slip. If you're on TRT and your provider added an AI without discussing your symptoms or explaining why, that warrants a conversation. The creator's instinct to question routine AI prescribing is sound. The execution just needed a sharper edge around when AI use is actually appropriate.
- Estradiol elevation without symptoms is not a universal indication for anastrozole.
- Anastrozole side effects including joint pain, mood changes, and low libido are clinically documented.
- Any changes to your hormone protocol should go through your prescribing provider, not a TikTok comment section.